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The protective effect of Capparis ovata in acute hepatotoxicity induced by paracetamol
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Background/aim: To investigate the efficiency of Capparis ovata as a protective agent against acute paracetamol toxicity of the liver.
Materials and methods: A total of 36 Wistar albino rats were divided into 4 groups: 1) paracetamol, 2) Capparis ovata + paracetamol,
3) Capparis ovata, and 4) control. Groups 2 and 3 were given Capparis ovata and Groups 1 and 4 distilled water for 8 days. On day 8,
3000 mg kg–1 paracetamol was administered orally to Groups 1 and 2. Samples were taken on day 9. AST, ALT, total bilirubin, direct
bilirubin, GGT, and ALP levels were assessed. Lipid peroxidation markers and thiobarbituric acid-reactive substance (TBARS) levels
were measured in the blood and liver. Liver tissues were evaluated histologically.
Results: AST, ALT, and total bilirubin levels were lower in Group 2 than in Group 1 (P < 0.05). TBARS levels were lower in Groups 2 (P
= 0.000), 3 (P = 0.001), and 4 (P = 0.001) than in Group 1. Degenerative findings were lower in the Capparis ovata + paracetamol group
than in the paracetamol group (P < 0.05).
Conclusion: It can be concluded that Capparis ovata has a protective effect on the liver, both histopathologically and biochemically,
against paracetamol-induced liver injury.
Key words: Antioxidant, Capparis ovata, hepatotoxicity, paracetamol

1. Introduction
Paracetamol is in widespread use as an effective analgesic and
antipyretic. The liver is a vital organ for the detoxification of
toxic substances present in the body, and hepatic injury is
associated with excessive exposure to toxicants. An overdose
of paracetamol has a toxic effect, which causes liver injury
both in experimental animals and humans. Its toxicity has
been shown to be initiated by cytochrome P450 metabolism
to N-acetyl-p-benzoquinone imine (NAPQI) (1). The most
common cause of acute liver failure worldwide is paracetamol,
which is usually a nonprescribed drug. The current available
treatment with N-acetylcysteine significantly reduces liver
damage in the early stages; however, clinical studies have
shown that there is no effective and safe way to prevent it
completely (2). There have been many studies on this subject,
but none have determined a treatment that is reliable,
effective, and accessible. There is a need to develop new drugs
or safer options from the currently available compounds in
order to provide hepatoprotection.
Capparis ovata belongs to the family Capparidaceae
and is a long-lasting shrubby plant found throughout the
* Correspondence: makcam32@gmail.com

Mediterranean basin. Capparis occurs in various types
(more than 350) and grows naturally in many different
regions worldwide. For centuries it has been known as a
traditional herbal medicine for its diuretic, antihypertensive,
hypoglycemic, antihepatotoxic, analgesic, and hypolipidemic
effects (3,4). Previous chemical studies have reported that
alkaloids, lipids, polyphenols, ﬂavonoids, and glucosinolates
are present in the plant. Furthermore, Capparis extract is
reported to be rich in antioxidants such as α-tocopherol,
γ-tocopherol, and sitosterol, as well as in ﬂavonoids such as
kaempferol, rutoside quercetin, and quercetin derivatives (5).
Thiobarbituric acid-reactive substances (TBARS)
are formed as a byproduct of lipid peroxidation (i.e. as
degradation products of fats), which can be detected by
the TBARS assay using thiobarbituric acid as a reagent.
An assay of TBARS measures malondialdehyde (MDA)
present in the sample, as well as malondialdehyde
generated from lipid hydroperoxides by the hydrolytic
conditions of the reaction.
This study was undertaken to evaluate the
hepatoprotective effect of C. ovata on paracetamol-

561

DOGAN et al. / Turk J Med Sci
induced hepatotoxicity in rats through biochemical,
antioxidant, and histological assessments, as this has not
been previously investigated.
2. Materials and methods
2.1. Animals
A total of 36 female Wistar albino rats weighing 145–191 g
(4–5 weeks old) were used in the study. The animals were
kept in a 12-h light/dark cycle and allowed free access to
food and water. All experiments were performed at a room
temperature of 22–24 °C. The experimental protocol of
the current study was approved by the Ethics Committee
of the Medical Faculty of Süleyman Demirel University.
The animals were kept and treated in accordance with
the Animal Welfare Act and Guide for the Care and Use
of Laboratory Animals prepared by Süleyman Demirel
University.
2.2. Extraction of Capparis ovata extracts
The C. ovata samples were collected from the area around
Isparta, in the Mediterranean region of Turkey. Distillated
water extracts of the ﬂowers were prepared at the Forestry
Industrial Engineering Department of Süleyman Demirel
University, Isparta, Turkey. The total phenols were
measured as 292 µg L–1 and ﬂavonoids as 170 µg L–1 with
a T80 + UV/VIS spectrometer (Germany). One gram of
Capparis flowers was put into 50 mL of distilled water,
boiled for 10 min, cooled for 15 min, and then brought
to a 2% solution (2 mg/100 mL) (6), and 1.5 mL was
administered by gavage.
2.3. Experimental design
Thirty-six animals were randomly divided into 4 groups
as follows:
Group 1: Paracetamol group (PS, n = 10): 1.5 mL of
distilled water was given orally via gastric gavage for 8
days. On day 8, 3000 mg/kg paracetamol was administered
orally (7).
Group 2: C. ovate + paracetamol (CAP + PS, n = 10): 1.5
mL of C. ovata was administered orally to the animals for 8
days. On day 8, 3000 mg/kg paracetamol was administered
orally.
Group 3: C. ovata (CAP, n = 8): 1.5 mL of C. ovata was
given orally for 8 days.
Group 4: Control (C, n = 8): 1.5 mL of distilled water
was given orally for 8 days.
2.4. Anesthesia, blood collection, and preparation of
blood samples
Twenty-four hours after paracetamol administration,
on day 9, the rats were anesthetized with a cocktail of
ketamine hydrochloride (80 mg kg–1) and xylazine (10
mg kg–1) administered i.p. before the sacrifice of each rat
and the withdrawal of blood samples. Blood (4–6 mL) was
taken from the aorta using a sterile injector. Blood samples
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were centrifuged at 5000 × g for 5 min and serum was
recovered. At the end of the study, the abdomen of the rats
was opened under anesthesia through a midline incision,
and the right lobes of the liver were removed for histologic
examination.
2.5. Biochemical parameters
A Beckman Coulter Inc. (Japan) autoanalyzer was
used to determine the serum activities of aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
γ-glutamyl transferase (GGT), total bilirubin (T. Bil.),
direct bilirubin (D. Bil.), and alkaline phosphatase (ALP).
2.6. Lipid peroxidation (TBARS) determinations
TBARS was determined by the double heating method
on serum and liver tissues. The method consisted of a
spectrophotometric measurement of the color produced
during the reaction to thiobarbituric acid (TBA) with
MDA. The concentration of TBARS was calculated by the
absorbance coefficient of MDA–TBA complex as expressed
in the serum (μM/mL) and liver (μM/g tissue).
2.7. Histopathological examinations
For light microscopic evaluation, sections of each liver
were ﬁxed in 10% neutral phosphate-buffered formalin
solution. Following dehydration in an ascending series of
ethanol solutions (70%, 80%, 96%, 100%), tissue samples
were cleaned in xylene and embedded in parafﬁn. The
parafﬁn-embedded specimens were cut into 5-μm-thick
sections, stained with hematoxylin and eosin (H&E), and
examined using a light microscope (Olympus BX50). The
liver tissues were examined by a histologist (MÖ), who was
blinded to the protocol. The liver tissues were examined
for connective tissue growth, hemorrhage, mononuclear
cell infiltration, necrotic cells, pyknotic-core cells,
apoptosis, granular degeneration, bile duct proliferation,
and hygroscopic-core cells, as described by Abdel-Wahhab
et al. (8). All findings were scored as (– = 0), (+ = 1), (++
= 2), or (+++ = 3).
2.8. Statistical analysis
The Kruskal–Wallis test was used to compare the
biochemical data and histopathologic scores of the
multiple groups. For two-group comparisons, the Mann–
Whitney U test was performed and a significance level
of P < 0.05 was accepted. The results were expressed as
mean ± standard deviation (SD). Statistical analyses were
performed with SPSS 15.0 (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Biochemical results
The effects of C. ovata on the paracetamol-induced
modiﬁcation on the serum AST, ALT, GGT, ALP, T. Bil,
and D. Bil. levels are shown in Table 1. AST, ALT, and
T. Bil. levels were lower in Group 2 (CAP + PS) than in
Group 1 (PS) (P < 0.05).
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Table 1. Serum AST, ALT, GGT, ALP, and bilirubin levels.
Group 1
(PS)
n = 10

Group 2
(PS + CAP)
n = 10

Group 3
(CAP)
n=8

Group 4
(C)
n=8

AST (U/L)

189.50 ± 39.70a,g

108.10 ± 4.37d

113.75 ± 5.44

109.00 ± 7.30

ALT (U/L)

112.12 ± 20.09b,h

64.90 ± 2.86e

52.00 ± 2.99

48.12 ± 2.15

T. Bil. (mg/dL)

0.15 ± 0.015c,i

0.10 ± 0.013f

0.10 ± 0.009

0.09 ± 0.004

D. Bil. (mg/dL)

0.03 ± 0.005

0.02 ± 0.003

0.02 ± 0.002

0.03 ± 0.002

GGT (U/L)

1.25 ± 0.16

1.60 ± 0.26

1.75 ± 0.31

1.62 ± 0.26

ALP (U/L)

252.75 ± 46.99

226.50 ± 22.29

224.50 ± 22.12

213.37 ± 27.35

Data are expressed as means ± SEM. PS: paracetamol, CAP: Capparis ovata, C: control.
P = 0.027 versus control group; bP = 0.003 versus control group; cP = 0.011 versus control group; dP = 0.033 versus PS
group; eP = 0.029 versus PS group; fP = 0.025 versus PS group; g P = 0.045 versus CAP group; hP = 0.006 versus CAP
group; iP = 0.031 versus CAP group.
a

3.2. Results of lipid peroxidation (TBARS)
The effects of C. ovata on the paracetamol-induced
modiﬁcation in the serum and liver tissue TBARS levels
are shown in Figure 1. Liver tissues and blood TBARS
levels were lower in Group 2 (CAP + PS) (P < 0.0001
for both), Group 3 (CAP) (P < 0.0001 and P = 0.001,
respectively), and Group 4 (control) (P < 0.0001 and P =
0.001, respectively) than in Group 1 (PS).
3.3. Results of histopathological changes
The histological findings of degeneration scores are shown
in Table 2. The histological score of Group 2 (CAP +
PS) was lower than that of Group 1 (PS) (P < 0.05). The
histopathological appearance of the liver tissue samples is
shown in Figures 2–4.

4. Discussion
To the best of our knowledge, this is the first study to
investigate C. ovata as protection against paracetamolinduced hepatotoxicity.
Analgesic toxicity is the leading cause of toxicity in
Turkey, similarly to most developed countries (9,10) .The
most frequent agent is reported to be paracetamol (11).
Previous studies have shown that Capparis species have
antioxidant activity and liver protection effects. In one
study, the antioxidant activity of methanolic acid extract
was shown to depend on the phenol it contained (12).
Germano et al. (3) reported that p-methoxybenzoic acid
in Capparis spinosa extract prepared with methanol has a
protective effect on hepatotoxicity when prepared in vivo

5.0
4.5
4.0
3.5
3.0
2.5

Liver tissues TBARS (µM/g)

2.0

Serum TBARS (µM/mL)

1.5
1.0
0.5
0

Group 1*
(PS)

Group 2
(PS+CAP)

Group 3 (CAP)

Group 4
(CONTROL)

Figure 1. Levels of TBARS in liver and serum.
PS: paracetamol, CAP: Capparis ovata., *Group 1 is compared with all groups: P < 0.05.
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Table 2. The histopathologic scores of groups.
Group 1
(PS)*

Group 2
(PS + CAP)

Group 3
(CAP)

Group 4
(C)

Connective tissue growth

2.00 ± 0.53a

1.12 ± 0.64

0.37 ± 0.51

0

Granular degenerations

2.50 ± 0.75

b

1.00 ± 0.53

0.37 ± 0.51

0

Mononuclear cell infiltration

2.50 ± 0.53c

1.12 ± 0.35

0.12 ± 0.35

0

Necrotic cells

2.00 ± 0.53d

1.00 ± 0.53

0.25 ± 0.46

0

Vascular congestion

2.62 ± 0.51

1.00 ± 0.53

0.25 ± 0.46

0

e

PS: paracetamol, CAP: Capparis ovata, C: control. *Group 1 is compared with all groups: P < 0.05.
a
P = 0.002 versus PS + CAP group; bP < 0.0001 versus PS + CAP group; cP < 0.0001 versus PS + CAP group; dP = 0.002
versus PS + CAP group; e versus PS + CAP group P = 0.000.

Figure 2. Histologic findings of Group 1 (PS). Connective
tissue growth (thin arrow), infiltration (thick arrow), bile duct
proliferation (star) (H&E, 10×).

Figure 3. Histologic findings of Group 2 (PS + CAP). Infiltration
(thin arrow), granular degeneration (thick arrow) (H&E, 10×).

with carbon tetrachloride (CCl4) and paracetamol, and in
vitro with thioacetamide and galactosemia. Siracusa et al.
(13) demonstrated that phenolic acid in Capparis spinosa
has an antioxidant function. In a study by Bonina et al.,
antioxidant activity was reported due to flavonoids and
hydroxycinnamic contained in Capparis (14). In addition,
Baijal et al. (15) reported that Liv. 52 DS tablets containing
Capparis spinosa have a liver protection effect when used
against acute hepatitis. In a study by Goyal et al., Capparis
decidua extracts were used and a decrease was determined
in plasma triglycerides, total lipid, and phospholipid
concentrations (16).

In a study on rats by Gadgoli et al. (12), the effect of
Capparis spinosa was researched against liver damage induced
with carbon tetrachloride (CCl4) and paracetamol. There
was a statistically significant decrease in AST, ALT, ALP, and
T. Bil. levels in the group that received CCl4 and Capparis
compared to the group that only received CCl4. In another
study on rats by Madhavan et al., the effect of Capparis
spinosa was investigated against acute hepatotoxicity induced
with acetaminophen. There was a statistically significant
decrease in AST, ALT, ALP, T. Bil., and D. Bil. levels in the
group administered acetaminophen and Capparis compared
to the group that only received acetaminophen (17).
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Figure 4. Histologic findings of Group 3 (a) and Group 4 (b), central vein (arrow) (H&E, 10×).

In the present study, there was a statistically significant
decrease in AST, ALT, ALP, and T. Bil. levels in the group
that received C. ovata and paracetamol compared to the
group that only received paracetamol, just as in other
studies conducted with other Capparis species.
In a study on rats by Anju Anıyathi et al., there was a
significant decrease in MDA levels, which was produced
by peroxidation and was controlled in the liver tissue
in the group that received Capparis brevispina against
hepatotoxicity created by paracetamol (18). In a study
performed by Kumar Mishra et al., the antioxidant activity
of an extract prepared from Capparis zeylanica and
ethanol was investigated (19). Daily extracts of Capparis
zeylanica for rats were administered as doses of 100 mg
kg–1, 200 mg kg–1, and 400 mg kg–1 with the gastric lavage
method. There was a significant decrease in serum TBARS
levels, especially in the 400 mg kg–1 dose of extract, when
compared to the control group.
In the current study, the oxidative situation to create
experimental toxicity by paracetamol in the groups was
evaluated by the TBARS method, both in the serum and
liver tissue. The TBARS levels in the paracetamol group
were high in the liver tissue and in the blood. The TBARS
levels in the group that received Capparis and paracetamol
were significantly lower compared to the paracetamol
group. However, there was no statistically significant
difference between the control and Capparis groups.
The results of this study have shown that C. ovata has a
protective effect against oxidative stress.
In a study on rats by Aghel et al., the protective effect
of Capparis spinosa on liver tissue was researched against

hepatotoxicity created by CCl4. There was less necrosis,
lymphoid infiltration, and lipid change in the group that
received CCl4 and Capparis spinosa compared to the group
that only received CCl4 (20).
In a study conducted with Capparis brevispina extract
prepared with ethanol against paracetamol-induced
hepatotoxicity in rats, cellular necrosis and mononuclear
infiltration were observed to be significantly less in the
group that received paracetamol and Capparis compared
to the paracetamol only group (18).
In the present study, there was a statistically
significant decrease in connective tissue growth, granular
degeneration, cell infiltration, and necrotic cell and
vascular conventions in the paracetamol and Capparis
group compared to the paracetamol-only group, similar to
the histopathological evaluation.
In conclusion, the results of this study have
demonstrated that C. ovata has antioxidant and
hepatoprotective activities, which is consistent with
other studies conducted with other species of Capparis.
However, this study can be considered to be an important
contribution to the literature, as it is the first experimental
study on weaned rats in particular, which shows the
activity of C. ovata against paracetamol toxicity for the
pediatric age group.
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